These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9227335)

  • 1. Neuroendocrine differentiation in lung cancer.
    Carey FA; Save VE
    J Pathol; 1997 May; 182(1):9-10. PubMed ID: 9227335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of so-called neuroendocrine lung tumors.
    Yesner R
    Exp Mol Pathol; 2001 Jun; 70(3):179-82. PubMed ID: 11417996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells.
    Chetty R
    Pathology; 2000 Aug; 32(3):209-12. PubMed ID: 10968398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping.
    Zaffaroni N; De Polo D; Villa R; Della Porta C; Collini P; Fabbri A; Pilotti S; Daidone MG
    J Pathol; 2003 Sep; 201(1):127-33. PubMed ID: 12950025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and novel therapeutics for neuroendocrine tumors of the lung.
    Jafri N; Salgia R
    J Biol Regul Homeost Agents; 2004; 18(3-4):275-90. PubMed ID: 15786694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent differentiation in neuroendocrine lung tumors.
    Brambilla E; Lantuejoul S; Sturm N
    Semin Diagn Pathol; 2000 May; 17(2):138-48. PubMed ID: 10839614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1.
    Walker GE; Antoniono RJ; Ross HJ; Paisley TE; Oh Y
    Oncogene; 2006 Mar; 25(13):1943-54. PubMed ID: 16302002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines.
    Gazdar AF; Kadoyama C; Venzon D; Park JG; Tsai CM; Linnoila RI; Mulshine JL; Ihde DC; Giaccone G
    J Natl Cancer Inst Monogr; 1992; (13):191-6. PubMed ID: 1327032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic characterization of neuroendocrine lung cancer cell lines.
    Lai SL; Brauch H; Knutsen T; Johnson BE; Nau MM; Mitsudomi T; Tsai CM; Whang-Peng J; Zbar B; Kaye FJ
    Anticancer Res; 1995; 15(2):225-32. PubMed ID: 7762988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lung tumours under the microscope].
    Wiechmann V
    MMW Fortschr Med; 2007 Nov; 149(44):27-9. PubMed ID: 18078166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroendocrine lung tumors].
    Ranfaing E
    Ann Pathol; 1993; 13(6):414-21. PubMed ID: 8141935
    [No Abstract]   [Full Text] [Related]  

  • 12. Carcinomas of the lung with neuroendocrine differentiation.
    Carter D; Yesner R
    Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine tumors of the ovary--a review.
    Kupryjańczyk J
    Verh Dtsch Ges Pathol; 1997; 81():253-9. PubMed ID: 9474878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of neuroendocrine differentiation in lung cancer cell lines featured by cytomorphology, markers, and their corresponding tumors.
    Linnoila RI
    J Cell Biochem Suppl; 1996; 24():92-106. PubMed ID: 8806093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors.
    Folpe AL; Gown AM; Lamps LW; Garcia R; Dail DH; Zarbo RJ; Schmidt RA
    Mod Pathol; 1999 Jan; 12(1):5-8. PubMed ID: 9950155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular sociology applied to neuroendocrine tumors of the lung: quantitative model of neoplastic architecture.
    Bigras G; Marcelpoil R; Brambilla E; Brugal G
    Cytometry; 1996 May; 24(1):74-82. PubMed ID: 8723905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer.
    Petrović M; Baskić D; Banković D; Ilić N
    Biomarkers; 2011 Jun; 16(4):311-20. PubMed ID: 21595568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
    Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
    Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchopulmonary neuroendocrine tumors.
    Gustafsson BI; Kidd M; Chan A; Malfertheiner MV; Modlin IM
    Cancer; 2008 Jul; 113(1):5-21. PubMed ID: 18473355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.